Research Article
Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals
Table 3
Status of cellular immunity in patients with and without type 2 diabetes.
| | Variables | Normal range | NDM () | T2D () | value | | Median | Increased no. (%) | Decreased no. (%) | Median | Increased no. (%) | Decreased no. (%) |
| | T (%) | 56-86 | 67.0 | 0 (0.0%) | 4 (12.1%) | 62.9 | 0 (0.0%) | 9 (23.1%) | 0.059 | | T (/μL) | 723-2737 | 983 | 0 (0.0%) | 9 (27.3%) | 679 | 0 (0.0%) | 19 (48.7%) | | | Th (%) | 33-58 | 41.1 | 1 (3.0%) | 6 (18.2%) | 42.0 | 0 (0.0%) | 1 (2.6%) | 0.926 | | Th (/μL) | 404-1612 | 604 | 0 (0.0%) | 8 (24.2%) | 451 | 0 (0.0%) | 6 (15.4%) | | | Tc (%) | 13-39 | 24.0 | 2 (6.1%) | 4 (12.1%) | 18.7 | 0 (0.0%) | 18 (46.2%) | | | Tc (/μL) | 220-1129 | 328 | 0 (0.0%) | 12 (36.4%) | 203 | 0 (0.0%) | 22 (66.7%) | | | Th/Tc | 0.9-2.0 | 2.12 | 15 (45.5%) | 3 (9.1%) | 2.54 | 22 (56.4%) | 0 (0.0%) | 0.221 | | B (%) | 5-22 | 13.4 | 4 (12.1%) | 0 (0.0%) | 19.4 | 12 (30.8%) | 0 (0.0%) | | | B (/μL) | 80-616 | 187 | 1 (3.0%) | 2 (6.1%) | 170.3 | 1 (2.6%) | 5 (15.2%) | 0.384 | | NK (%) | 5-26 | 17.3 | 2 (6.1%) | 0 (0.0%) | 16.4 | 3 (7.7%) | 3 (7.7%) | 0.810 | | NK (/μL) | 84-724 | 242 | 0 (0.00%) | 2 (6.1%) | 186 | 1 (2.6%) | 14 (35.9%) | |
|
|
